A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 145,706 shares of TLRY stock, worth $254,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,706
Previous 130,796 11.4%
Holding current value
$254,985
Previous $323,000 25.08%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$1.62 - $2.85 $24,154 - $42,493
14,910 Added 11.4%
145,706 $242,000
Q1 2024

Apr 24, 2024

SELL
$1.6 - $2.48 $10,254 - $15,894
-6,409 Reduced 4.67%
130,796 $323,000
Q4 2023

Feb 09, 2024

BUY
$1.66 - $2.41 $94,341 - $136,965
56,832 Added 70.71%
137,205 $316,000
Q3 2023

Oct 24, 2023

SELL
$1.55 - $3.31 $56,846 - $121,394
-36,675 Reduced 31.33%
80,373 $192,000
Q2 2023

Jul 13, 2023

SELL
$1.52 - $2.78 $24,207 - $44,274
-15,926 Reduced 11.98%
117,048 $183,000
Q1 2023

May 11, 2023

SELL
$2.36 - $3.35 $21,310 - $30,250
-9,030 Reduced 6.36%
132,974 $336,000
Q4 2022

Feb 08, 2023

SELL
$2.58 - $4.68 $3,490 - $6,332
-1,353 Reduced 0.94%
142,004 $382,000
Q3 2022

Oct 17, 2022

BUY
$2.7 - $4.3 $19,753 - $31,458
7,316 Added 5.38%
143,357 $394,000
Q2 2022

Jul 13, 2022

SELL
$3.11 - $7.48 $273,194 - $657,073
-87,844 Reduced 39.24%
136,041 $424,000
Q1 2022

May 12, 2022

BUY
$4.88 - $8.56 $636,342 - $1.12 Million
130,398 Added 139.48%
223,885 $1.74 Million
Q4 2021

Feb 03, 2022

SELL
$7.03 - $13.03 $390,959 - $724,637
-55,613 Reduced 37.3%
93,487 $657,000
Q3 2021

Nov 02, 2021

BUY
$11.11 - $17.84 $346,854 - $556,964
31,220 Added 26.48%
149,100 $1.68 Million
Q2 2021

Aug 10, 2021

BUY
$13.68 - $22.34 $903,290 - $1.48 Million
66,030 Added 127.35%
117,880 $2.13 Million
Q1 2021

May 07, 2021

BUY
$9.0 - $63.91 $190,629 - $1.35 Million
21,181 Added 69.06%
51,850 $1.18 Million
Q4 2020

Feb 04, 2021

BUY
$4.82 - $10.1 $48,580 - $101,797
10,079 Added 48.95%
30,669 $253,000
Q3 2020

Oct 29, 2020

BUY
$4.7 - $8.7 $9,056 - $16,764
1,927 Added 10.33%
20,590 $99,000
Q2 2020

Jul 27, 2020

BUY
$5.54 - $10.81 $1,939 - $3,783
350 Added 1.91%
18,663 $132,000
Q1 2020

May 08, 2020

BUY
$2.47 - $21.36 $45,233 - $391,165
18,313 New
18,313 $125,000
Q4 2019

Feb 04, 2020

SELL
$15.72 - $24.88 $184,144 - $291,444
-11,714 Closed
0 $0
Q3 2019

Nov 06, 2019

BUY
$24.74 - $49.3 $2,350 - $4,683
95 Added 0.82%
11,714 $289,000
Q3 2019

Oct 28, 2019

BUY
$24.74 - $49.3 $287,454 - $572,816
11,619 New
11,619 $287,000
Q2 2019

Aug 15, 2019

SELL
$34.66 - $63.73 $359,978 - $661,899
-10,386 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$64.85 - $100.15 $243,771 - $376,463
3,759 Added 56.72%
10,386 $0
Q4 2018

Feb 05, 2019

SELL
$65.89 - $165.64 $78,540 - $197,442
-1,192 Reduced 15.24%
6,627 $467,000
Q3 2018

Nov 02, 2018

BUY
$22.1 - $214.06 $172,799 - $1.67 Million
7,819 New
7,819 $0

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $1.07B
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.